PANX1 and polycystic kidney disease: In particular, 12f was a more potent Panx1 blocker than the reference compound CBX (IC50 = 2.7 μM versus IC50 = 7.1 μM), and its profile was further investigated in a cell culture model of polycystic kidney disease.